• 1. Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
  Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227
• 2. An ionic liquid loaded magnetically confined polymeric mesoporous adsorbent for extraction of parabens from environmental and cosmetic samples?
  Masrudin Md Yusoff,Muggundha Raoov,Noorfatimah Yahaya,Noorashikin Md Salleh RSC Adv., 2017,7, 35832-35844
• 3. Aggregation-induced emission based on a fluorinated macrocycle: visualizing spontaneous and ultrafast solid-state molecular motions at room temperature via F?F interactions?
  Mei Zhang,Jingjing Guo,Tingting Liu,Zhanyu He,Majeed Irfan,Zujin Zhao,Zhuo Zeng J. Mater. Chem. C, 2020,8, 14919-14924
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Primary amines

Recent Advances in the Study of 2-(4-chloro-5-methyl-1H-pyrazol-1-yl)ethan-1-amine (CAS: 1006468-92-3)

2-(4-chloro-5-methyl-1H-pyrazol-1-yl)ethan-1-amine (CAS: 1006468-92-3) is a pyrazole derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential therapeutic applications. Recent studies have focused on its synthesis, pharmacological properties, and mechanisms of action, particularly in the context of drug discovery and development. This research brief aims to summarize the latest findings related to this compound, providing insights into its current applications and future potential.

The compound's structural features, including the pyrazole ring and the chloro-methyl substituents, make it a versatile scaffold for the design of bioactive molecules. Recent synthetic approaches have optimized the yield and purity of 2-(4-chloro-5-methyl-1H-pyrazol-1-yl)ethan-1-amine, enabling more efficient large-scale production. These advancements are crucial for further pharmacological evaluations and potential commercialization.

Pharmacological studies have revealed that 2-(4-chloro-5-methyl-1H-pyrazol-1-yl)ethan-1-amine exhibits promising activity in modulating specific biological targets. For instance, recent in vitro and in vivo experiments have demonstrated its efficacy as a potential inhibitor of certain enzymes involved in inflammatory pathways. These findings suggest its potential application in the treatment of inflammatory diseases, although further clinical validation is required.

In addition to its anti-inflammatory properties, recent research has explored the compound's role in oncology. Preliminary data indicate that 2-(4-chloro-5-methyl-1H-pyrazol-1-yl)ethan-1-amine may interfere with signaling pathways critical for cancer cell proliferation. These studies, however, are still in the early stages, and more comprehensive investigations are needed to elucidate its mechanisms and therapeutic window.

The safety profile of 2-(4-chloro-5-methyl-1H-pyrazol-1-yl)ethan-1-amine has also been a focus of recent research. Toxicological assessments have shown that the compound has a favorable safety margin in preclinical models, with minimal off-target effects. These results support its potential as a candidate for further drug development, provided that subsequent studies confirm these findings in human trials.

In conclusion, 2-(4-chloro-5-methyl-1H-pyrazol-1-yl)ethan-1-amine (CAS: 1006468-92-3) represents a promising compound in the field of medicinal chemistry. Its diverse pharmacological activities, coupled with advancements in synthetic methodologies, position it as a valuable scaffold for future drug discovery efforts. Continued research is essential to fully unlock its therapeutic potential and translate these findings into clinical applications.

• 1004643-52-0((4-Chloro-3,5-dimethyl-1H-pyrazol-1-yl)-acetonitrile)
• 951235-39-5(3-(4-chloro-5-methylpyrazol-1-yl)propan-1-amine)
• 1332531-21-1((4-chloro-1-ethyl-1H-pyrazol-5-yl)methylamine)
• 1002032-40-7((4-Chloro-1-ethyl-1H-pyrazol-5-yl)methylamine)
• 1052549-05-9(2-(4-Chloro-3,5-dimethyl-pyrazol-1-yl)-ethylamine hydrochloride)
• 118020-41-0(1H-Pyrazole, 4-chloro-, monohydrochloride)
• 956786-61-1(3-(4-Chloro-3,5-dimethyl-1H-pyrazol-1-yl)propan-1-amine)
• 925634-46-4(2-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)ethanamine)
• 1006480-06-3(2-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)ethan-1-ol)
• 1006348-49-7(3-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)propan-1-ol)